{
    "medicine_id": "1f275b8a9aba24a6b00b26f8a7b95ccd5ef2e58d",
    "platform_id": "6189",
    "metadata": {
        "name": "Multi Action ACTIFED Dry Coughs",
        "composition": "Multi Action ACTIFED Dry Coughs contains 1 25 mg triprolidine hydrochloride 30 mg pseudoephedrine hydrochloride and 10 mg dextromethorphan hydrobromide in each 5 ml",
        "clinical_particulars": {
            "therapeutic_indications": "Multi Action ACTIFED Dry Coughs is indicated for the symptomatic relief of upper respiratory tract disorders which are benefited by the combination of a nasal decongestant a histamine H 1 receptor antagonist and an antitussive",
            "contraindications": {
                "disease": "Multi Action ACTIFED Dry Coughs is contraindicated in individuals with known hypersensitivity to dextromethorphan pseudoephedrine triprolidine or to any of the excipients listed in section 6 1 Concomitant use of other sympathomimetic decongestants beta blockers selective serotonin reuptake inhibitors SSRIs or monoamine oxidase inhibitors MAOIs or within 14 days of stopping MAOI treatment see section 4 5 The concomitant use of this product and MAOIs may cause a rise in blood pressure and or hypertensive crisis There is a risk of serotonin syndrome with dextromethorphan see section 4 5 Cardiovascular disease including hypertension Diabetes mellitus Phaeochromocytoma Hyperthyroidism Closed angle glaucoma Severe renal impairment Dextromethorphan should not be given to patients in or at risk of developing respiratory failure Not to be used in children under the age of 12 years",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Sorbitol solution (70 %) (E420);Sucrose;Sodium benzoate;Methyl hydroxybenzoate (E218);Ponceau 4R (E124) (sodium);Ethanol (96%);Blackberry AD16554 (ethanol);Levomenthol;Vanillin;Purified water",
                "incompatibilities": "Not applicable"
            }
        },
        "revision_date": "2022-05-09"
    }
}